Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109598247 | 10959824 | 7 | F | 20150323 | 20160707 | 20150327 | 20160712 | EXP | DE-ROCHE-1555623 | ROCHE | 0.00 | F | Y | 76.00000 | KG | 20160712 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109598247 | 10959824 | 1 | PS | Trastuzumab | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | MAINTAINANCE DOSE | 103792 | 2 | MG/KG | SOLUTION FOR INFUSION | /wk | ||||||
| 109598247 | 10959824 | 2 | SS | Trastuzumab | TRASTUZUMAB | 1 | Subcutaneous | MOST RECENT DOSE ON: 07/APR/2015 | UNKNOWN | 103792 | 600 | MG | SOLUTION FOR INJECTION | Q3W | |||||
| 109598247 | 10959824 | 3 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | 0 | 80 | MG/M**2 | /wk | ||||||||
| 109598247 | 10959824 | 4 | C | CLEMASTIN | CLEMASTINE | 1 | Unknown | 0 | |||||||||||
| 109598247 | 10959824 | 5 | C | DEXAMETHASON | DEXAMETHASONE | 1 | Unknown | 0 | Q3W | ||||||||||
| 109598247 | 10959824 | 6 | C | DEXAMETHASON | DEXAMETHASONE | 1 | Unknown | 0 | |||||||||||
| 109598247 | 10959824 | 7 | C | VALSARTAN. | VALSARTAN | 1 | Oral | 0 | 160 | MG | |||||||||
| 109598247 | 10959824 | 8 | C | GRANISETRON | GRANISETRON | 1 | Unknown | 0 | Q3W | ||||||||||
| 109598247 | 10959824 | 9 | C | GRANISETRON | GRANISETRON | 1 | Unknown | 0 | |||||||||||
| 109598247 | 10959824 | 10 | C | APREPITANT. | APREPITANT | 1 | Unknown | 0 | |||||||||||
| 109598247 | 10959824 | 11 | C | Filgrastim | FILGRASTIM | 1 | Unknown | 0 | |||||||||||
| 109598247 | 10959824 | 12 | C | RANITIDIN | RANITIDINE HYDROCHLORIDE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 109598247 | 10959824 | 1 | Breast cancer |
| 109598247 | 10959824 | 2 | HER-2 positive breast cancer |
| 109598247 | 10959824 | 3 | HER-2 positive breast cancer |
| 109598247 | 10959824 | 7 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 109598247 | 10959824 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 109598247 | 10959824 | Cardiac failure | |
| 109598247 | 10959824 | Deep vein thrombosis | |
| 109598247 | 10959824 | Pulmonary embolism |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 109598247 | 10959824 | 1 | 20150105 | 20150309 | 0 | |
| 109598247 | 10959824 | 2 | 20150316 | 20160111 | 0 | |
| 109598247 | 10959824 | 3 | 20141229 | 20150309 | 0 | |
| 109598247 | 10959824 | 4 | 20141229 | 20150309 | 0 | |
| 109598247 | 10959824 | 5 | 20141006 | 20150309 | 0 | |
| 109598247 | 10959824 | 6 | 20141006 | 20150309 | 0 | |
| 109598247 | 10959824 | 8 | 20141006 | 20150309 | 0 | |
| 109598247 | 10959824 | 9 | 20141006 | 20150309 | 0 | |
| 109598247 | 10959824 | 10 | 20141006 | 20141208 | 0 | |
| 109598247 | 10959824 | 11 | 20141102 | 20141215 | 0 | |
| 109598247 | 10959824 | 12 | 20141229 | 20150309 | 0 |